S

Solid Biosciences

SLDB

8.70000
USD
-0.24
(-2.68%)
مغلق
حجم التداول
9,739
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
220,764,756
أصول ذات صلة
ABT
4.220
(3.98%)
110.150 USD
B
BNTX
-5.530
(-6.42%)
80.570 USD
GILD
0.470
(0.62%)
76.510 USD
MRK
0.680
(0.60%)
113.800 USD
MRNA
-25.020
(-20.99%)
94.160 USD
N
NVAX
-0.250
(-1.95%)
12.560 USD
PFE
0.115
(0.38%)
30.650 USD
REGN
13.14
(1.22%)
1,091.19 USD
VRTX
9.75
(1.97%)
505.40 USD
الأخبار المقالات

العنوان: Solid Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.